NCT05285787View on ClinicalTrials.gov

A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
End-Stage Renal Disease (ESRD)
Interventions
DRUG

EPN-701 (Oral)

MK-7

Trial Locations (1)

30904

Southeastern Clinical Research Institute, LLC, Augusta

Sponsors
All Listed Sponsors
lead

Epizon Pharma, Inc.

OTHER